| FDA approves GlaxoSmithKline's VOTRIENT(TM) for advanced renal cell cancer - Reuters |
|
|
ReutersVOTRIENT will join existing targeted therapies to provide physicians with a new oral treatment option to their patients with advanced renal cell cancer. ... read more |